NASDAQ: PBM
Psyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?

Insider buying vs selling

Have Psyence Biomedical Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PBM insiders and whales buy or sell their stock.

PBM Shareholders

What type of owners hold Psyence Biomedical Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc Gregory Balkin1,312.45%7,455,000$20.95MInsider
Newcourt Spac Sponsor LLC161.97%920,000$2.59MInsider
Polar Asset Management Partners Inc93.31%530,000$1.49MInsider
Parallel Advisors LLC48.41%275,000$772.75kInstitution
Sabby Management LLC3.58%20,328$57.12kInstitution
Advisorshares Investments LLC0.78%4,448$12.50kInstitution
Goldman Sachs Group Inc0.66%3,749$10.53kInsider
Bank Of America Corp0.59%3,340$9.39kInstitution
Ubs Group Ag0.34%1,956$5.50kInstitution
Stonehage Fleming Financial Services Holdings Ltd0.10%561$1.58kInstitution

1 of 2

PBM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBM3.32%96.68%
SPRC22.00%0.00%
PTIX15.63%7.78%
REVB1.02%98.98%Net Buying
AEON4.44%95.56%Net Buying

Psyence Biomedical Stock Ownership FAQ

Who owns Psyence Biomedical?

Psyence Biomedical (NASDAQ: PBM) is owned by 53.81% institutional shareholders, 1,568.38% Psyence Biomedical insiders, and 0.00% retail investors. Marc Gregory Balkin is the largest individual Psyence Biomedical shareholder, owning 7.46M shares representing 1,312.45% of the company. Marc Gregory Balkin's Psyence Biomedical shares are currently valued at $20.95M.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.